US Stock MarketDetailed Quotes
BNOX Bionomics
- 0.980
- +0.021+2.18%
Trading Apr 18 13:16 ET
10.48MMarket Cap-367P/E (TTM)
0.999High0.959Low15.97KVolume0.960Open0.959Pre Close15.67KTurnover0.23%Turnover RatioLossP/E (Static)10.69MShares6.41052wk High0.56P/B6.95MFloat Cap0.87052wk Low--Dividend TTM7.09MShs Float22.000Historical High--Div YieldTTM4.15%Amplitude0.870Historical Low0.981Avg Price1Lot Size
About Bionomics Company
Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
Company Profile
SymbolBNOX
Company NameBionomics
Issue Price12.35
Founded1996
CEODr. Spyros Papapetropoulos, M.D.
MarketNASDAQ
Employees25
Securities TypeDR
ADS Ratio1.0 : 180.0
Fiscal Year Ends06-30
Address200 Greenhill Road
CityEastwood
ProvinceSouth Australia (SA)
CountryAustralia
Zip Code5063
Phone61-8-8150-7400
Websitehttp://www.bionomics.com.au
Company Executives
- Name
- Position
- Salary
- Dr. Spyros Papapetropoulos, M.D.
- President and Chief Executive Officer
- 919.77K
- Timothy M. Cunningham
- Chief Financial Officer
- --
- Liz Doolin
- Vice President, Clinical Development
- 357.03K
- Alan Fisher
- Chairman of the Board
- 87.00K
- Dr. Errol B. De Souza,PhD
- Director
- 3.09M
- David Wilson
- Independent Director
- 87.00K
- Dr. Jane Ryan
- Independent Director
- 86.72K
- Peter Miles Davies
- Independent Director
- 77.00K
- Aaron Weaver
- Independent Director
- 77.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg